Uro-Vaxom® versus placebo for the prevention of recurrent symptomatic urinary tract infections in participants with chronic neurogenic bladder dysfunction: a randomised controlled feasibility study

BACKGROUND: Patients with lower neurogenic bladder dysfunction are at an increased risk of suffering from recurrent urinary tract infections. Recurrent symptomatic urinary tract infection is occasionally treated with antibiotics as a prophylactic prevention strategy. This risks increasing the freque...

Descripción completa

Detalles Bibliográficos
Autores principales: Wade, Derick, Cooper, James, Derry, Fadel, Taylor, Julian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469220/
https://www.ncbi.nlm.nih.gov/pubmed/30992071
http://dx.doi.org/10.1186/s13063-019-3275-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469220/
https://www.ncbi.nlm.nih.gov/pubmed/30992071
http://dx.doi.org/10.1186/s13063-019-3275-x

Ejemplares similares